Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents

Background. WHO recommends HBV-negative babies in high-prevalence (8%) countries receive anti-HBV vaccination. Ghana initiated mass immunization in 2002, but concerns remain about vaccine effectiveness and long-term protection. We evaluated immune characteristics and factors following hepatitis B va...

Full description

Saved in:
Bibliographic Details
Main Authors: Samuel Asamoah Sakyi, Joseph Badu Gyapong, Ebenezer Krampah Aidoo, Alfred Effah, Simon Koffie, Oscar Simon Olympio Mensah, Isaac Arddey, Godwin Boakye, Stephen Opoku, Benjamin Amoani, Robert Amadu Ngala
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Advances in Virology
Online Access:http://dx.doi.org/10.1155/2024/9502939
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553035468898304
author Samuel Asamoah Sakyi
Joseph Badu Gyapong
Ebenezer Krampah Aidoo
Alfred Effah
Simon Koffie
Oscar Simon Olympio Mensah
Isaac Arddey
Godwin Boakye
Stephen Opoku
Benjamin Amoani
Robert Amadu Ngala
author_facet Samuel Asamoah Sakyi
Joseph Badu Gyapong
Ebenezer Krampah Aidoo
Alfred Effah
Simon Koffie
Oscar Simon Olympio Mensah
Isaac Arddey
Godwin Boakye
Stephen Opoku
Benjamin Amoani
Robert Amadu Ngala
author_sort Samuel Asamoah Sakyi
collection DOAJ
description Background. WHO recommends HBV-negative babies in high-prevalence (8%) countries receive anti-HBV vaccination. Ghana initiated mass immunization in 2002, but concerns remain about vaccine effectiveness and long-term protection. We evaluated immune characteristics and factors following hepatitis B vaccination among Ghanaian adolescents who received HBV vaccines. Methods. In this longitudinal cross-sectional study, 74 participants were enrolled from the Kumasi Metropolis, Ghana. Sociodemographic and lifestyle characteristics of participants were obtained using a questionnaire. Blood samples were obtained before and after booster administration for anti-HBsAg, IL-6, and IL-10 estimations using ELISA kit (Shanghai Chemical Ltd., China). Anti-HBsAg titers ≥10 mIU/ml were considered protective. Statistical analyses were done using SPSS version 26.0 and R programming language, p<0.05 was considered statistically significant. Results. We found 100% seroconversion rate, with 25.7% seroprotection rate (anti-HBsAg >10 mIU/ml). Gender (p=0.009), age (p=0.001), and exercising (p=0.044) were significantly associated with seroprotection. Following booster administration, 59.4% were hyporesponders (10 ≤ anti-HBsAg titre ≤99 mIU/ml) whilst 40.6% were good responders (anti-HBsAg titre ≥100 mIU/ml). Exercise (p=0.034) was significantly associated with immune response after booster administration. Moreover, we reported significant positive correlation between cytokines [IL-6 (r = 0.817, p<0.001) and IL-10 (r = 0.928, p<0.001)] and anti-HBsAg titre. Conclusion. Approximately two thirds of adolescents vaccinated at birth lack protective levels of antibodies against hepatitis B virus. Booster vaccines could aid in mounting protective levels of anti-HBsAg. Physical exercise was negatively associated with immune response to hepatitis B vaccinations.
format Article
id doaj-art-12edfc337a40462c9535e62f7848caf2
institution Kabale University
issn 1687-8647
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Advances in Virology
spelling doaj-art-12edfc337a40462c9535e62f7848caf22025-02-03T05:56:55ZengWileyAdvances in Virology1687-86472024-01-01202410.1155/2024/9502939Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian AdolescentsSamuel Asamoah Sakyi0Joseph Badu Gyapong1Ebenezer Krampah Aidoo2Alfred Effah3Simon Koffie4Oscar Simon Olympio Mensah5Isaac Arddey6Godwin Boakye7Stephen Opoku8Benjamin Amoani9Robert Amadu Ngala10Department of Molecular MedicineDepartment of Molecular MedicineDepartment of Medical Laboratory TechnologyDepartment of Molecular MedicineDepartment of Molecular MedicineDepartment of Molecular MedicineDepartment of Molecular MedicineDepartment of Molecular MedicineDepartment of NeurosurgeryDepartment of Biomedical SciencesDepartment of Molecular MedicineBackground. WHO recommends HBV-negative babies in high-prevalence (8%) countries receive anti-HBV vaccination. Ghana initiated mass immunization in 2002, but concerns remain about vaccine effectiveness and long-term protection. We evaluated immune characteristics and factors following hepatitis B vaccination among Ghanaian adolescents who received HBV vaccines. Methods. In this longitudinal cross-sectional study, 74 participants were enrolled from the Kumasi Metropolis, Ghana. Sociodemographic and lifestyle characteristics of participants were obtained using a questionnaire. Blood samples were obtained before and after booster administration for anti-HBsAg, IL-6, and IL-10 estimations using ELISA kit (Shanghai Chemical Ltd., China). Anti-HBsAg titers ≥10 mIU/ml were considered protective. Statistical analyses were done using SPSS version 26.0 and R programming language, p<0.05 was considered statistically significant. Results. We found 100% seroconversion rate, with 25.7% seroprotection rate (anti-HBsAg >10 mIU/ml). Gender (p=0.009), age (p=0.001), and exercising (p=0.044) were significantly associated with seroprotection. Following booster administration, 59.4% were hyporesponders (10 ≤ anti-HBsAg titre ≤99 mIU/ml) whilst 40.6% were good responders (anti-HBsAg titre ≥100 mIU/ml). Exercise (p=0.034) was significantly associated with immune response after booster administration. Moreover, we reported significant positive correlation between cytokines [IL-6 (r = 0.817, p<0.001) and IL-10 (r = 0.928, p<0.001)] and anti-HBsAg titre. Conclusion. Approximately two thirds of adolescents vaccinated at birth lack protective levels of antibodies against hepatitis B virus. Booster vaccines could aid in mounting protective levels of anti-HBsAg. Physical exercise was negatively associated with immune response to hepatitis B vaccinations.http://dx.doi.org/10.1155/2024/9502939
spellingShingle Samuel Asamoah Sakyi
Joseph Badu Gyapong
Ebenezer Krampah Aidoo
Alfred Effah
Simon Koffie
Oscar Simon Olympio Mensah
Isaac Arddey
Godwin Boakye
Stephen Opoku
Benjamin Amoani
Robert Amadu Ngala
Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
Advances in Virology
title Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
title_full Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
title_fullStr Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
title_full_unstemmed Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
title_short Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
title_sort evaluation of immune characteristics and factors associated with immune response following hepatitis b vaccination among ghanaian adolescents
url http://dx.doi.org/10.1155/2024/9502939
work_keys_str_mv AT samuelasamoahsakyi evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT josephbadugyapong evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT ebenezerkrampahaidoo evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT alfredeffah evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT simonkoffie evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT oscarsimonolympiomensah evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT isaacarddey evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT godwinboakye evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT stephenopoku evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT benjaminamoani evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents
AT robertamadungala evaluationofimmunecharacteristicsandfactorsassociatedwithimmuneresponsefollowinghepatitisbvaccinationamongghanaianadolescents